Transdermal therapeutic system (TTS) containing oxybutynin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 29, 2003
Grant Date -
N/A
app pub date -
Oct 26, 2000
filing date -
Mar 20, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A transdermal therapeutic system (TTS) for transcutaneous administration of oxybutynin over a period of several days, in addition to a method for the production of the TTS without the use of solvents, are disclosed. The TTS contains a matrix mass containing oxybutynin in the form of a self-adhesive layer. The matrix mass includes ammonium-group-containing (meth)acrylic polymers, at least one citric acid ester, and 5-25 wt. % oxybutynin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully